BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28235564)

  • 1. Candidate novel long noncoding RNAs, MicroRNAs and putative drugs for Parkinson's disease using a robust and efficient genome-wide association study.
    Mortezaei Z; Lanjanian H; Masoudi-Nejad A
    Genomics; 2017 Jul; 109(3-4):158-164. PubMed ID: 28235564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathway analysis of genome-wide association studies for Parkinson's disease.
    Song GG; Lee YH
    Mol Biol Rep; 2013 Mar; 40(3):2599-607. PubMed ID: 23238920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered Long Noncoding RNA Expression Precedes the Course of Parkinson's Disease-a Preliminary Report.
    Kraus TFJ; Haider M; Spanner J; Steinmaurer M; Dietinger V; Kretzschmar HA
    Mol Neurobiol; 2017 May; 54(4):2869-2877. PubMed ID: 27021022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide pathway-based association analysis identifies risk pathways associated with Parkinson's disease.
    Zhang M; Mu H; Shang Z; Kang K; Lv H; Duan L; Li J; Chen X; Teng Y; Jiang Y; Zhang R
    Neuroscience; 2017 Jan; 340():398-410. PubMed ID: 27840232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide contribution of common short-tandem repeats to Parkinson's disease genetic risk.
    Bustos BI; Billingsley K; Blauwendraat C; Gibbs JR; Gan-Or Z; Krainc D; Singleton AB; Lubbe SJ;
    Brain; 2023 Jan; 146(1):65-74. PubMed ID: 36347471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of non-coding RNAs in Parkinson's disease.
    Majidinia M; Mihanfar A; Rahbarghazi R; Nourazarian A; Bagca B; Avci ÇB
    Mol Biol Rep; 2016 Nov; 43(11):1193-1204. PubMed ID: 27492082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microarray analysis of an synthetic α-synuclein induced cellular model reveals the expression profile of long non-coding RNA in Parkinson's disease.
    Lin D; Liang Y; Jing X; Chen Y; Lei M; Zeng Z; Zhou T; Wu X; Peng S; Zheng D; Huang K; Yang L; Xiao S; Liu J; Tao E
    Brain Res; 2018 Jan; 1678():384-396. PubMed ID: 29137975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying the Association Between Alzheimer's Disease and Parkinson's Disease Using Genome-Wide Association Studies and Protein-Protein Interaction Network.
    Liu G; Bao X; Jiang Y; Liao M; Jiang Q; Feng R; Zhang L; Ma G; Chen Z; Wang G; Wang R; Zhao B; Li K
    Mol Neurobiol; 2015 Dec; 52(3):1629-1636. PubMed ID: 25370933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease and Parkinson's disease genome-wide association study top hits and risk of Parkinson's disease in Korean population.
    Chung SJ; Jung Y; Hong M; Kim MJ; You S; Kim YJ; Kim J; Song K
    Neurobiol Aging; 2013 Nov; 34(11):2695.e1-7. PubMed ID: 23820587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward identification of susceptibility genes for sporadic Parkinson's disease.
    Toda T; Momose Y; Murata M; Tamiya G; Yamamoto M; Hattori N; Inoko H
    J Neurol; 2003 Oct; 250 Suppl 3():III40-3. PubMed ID: 14579123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease-associated genetic variation is linked to quantitative expression of inflammatory genes.
    Pierce S; Coetzee GA
    PLoS One; 2017; 12(4):e0175882. PubMed ID: 28407015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIPA1L2, MIR4697, GCH1 and VPS13C loci and risk of Parkinson's diseases in Iranian population: A case-control study.
    Safaralizadeh T; Jamshidi J; Esmaili Shandiz E; Movafagh A; Fazeli A; Emamalizadeh B; Manafi N; Taghavi S; Tafakhori A; Darvish H
    J Neurol Sci; 2016 Oct; 369():1-4. PubMed ID: 27653855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases.
    Wu P; Zuo X; Deng H; Liu X; Liu L; Ji A
    Brain Res Bull; 2013 Aug; 97():69-80. PubMed ID: 23756188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the role of non-coding RNAs in the pathophysiology of Parkinson's disease.
    Rezaei O; Nateghinia S; Estiar MA; Taheri M; Ghafouri-Fard S
    Eur J Pharmacol; 2021 Apr; 896():173914. PubMed ID: 33508286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the Shared Genetic Etiology Between Parkinson's Disease and Depression.
    Reyes-Pérez P; García-Marín LM; Aman AM; Antar T; Flores-Ocampo V; Mitchell BL; Medina-Rivera A; Rentería ME
    J Parkinsons Dis; 2024; 14(3):483-493. PubMed ID: 38457145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct patterns of genetic variations in potential functional elements in long noncoding RNAs.
    Bhartiya D; Jalali S; Ghosh S; Scaria V
    Hum Mutat; 2014 Feb; 35(2):192-201. PubMed ID: 24178912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of Non-Coding RNAs as Novel Diagnostic Biomarkers in Parkinson's Disease.
    Manna I; Quattrone A; De Benedittis S; Iaccino E; Quattrone A
    J Parkinsons Dis; 2021; 11(4):1475-1489. PubMed ID: 34334422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of Long Non-coding RNA Expression Profiles in the Substantia Nigra of Parkinson's Disease.
    Ni Y; Huang H; Chen Y; Cao M; Zhou H; Zhang Y
    Cell Mol Neurobiol; 2017 Mar; 37(2):329-338. PubMed ID: 27151187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide identification of m
    Qiu X; He H; Huang Y; Wang J; Xiao Y
    Neurosci Lett; 2020 Oct; 737():135315. PubMed ID: 32827573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA variations in cardiometabolic diseases.
    Dechamethakun S; Muramatsu M
    J Hum Genet; 2017 Jan; 62(1):97-104. PubMed ID: 27305986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.